← Eichor
Study identifier: NCT06950125 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Evaluation of the JUICE HA® as an Anti-sarcopenia

Condition: Sarcopenia in Elderly  ·  Sponsor: China Medical University Hospital

PhaseNA
Planned participants60
Who can joinAll sexes, 65 Years to no upper limit
Healthy volunteersNo

About this study

This study plans to recruit 60 participants aged 65 years and older who have been diagnosed with sarcopenia by a physician. Participants will be randomly assigned into JUICE HA® supplement and placebo group. All of the participants will be asked to take 15 mL/day of JUICE HA® supplement or placebo group for 12 weeks. The aim of this trial is to evaluate the potential of JUICE HA® to enhance physiological status (muscle mass and functional fitness) and to improve the quality of life in patients with sarcopenia.

This description comes directly from the study's public registry record.

Talk to the study team

Chih-Hsueh Lin, Medical Master Degree  ·  +886422053366  ·  d5496lin@mail.cmu.edu.tw

Always discuss trial participation with your own doctor first.

Locations (1)

China Medical University HospitalTaichung, TaiwanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06950125